Ligand Pharm
(LGND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1989 | 12-1988 | |
| Cash Flows From Operating Activities | ||
| Net Income | -2,695 | -2,695 |
| Depreciation Amortization | 448 | 448 |
| Other Working Capital | -23 | -23 |
| Operating Cash Flow | $-2,269 | $-2,269 |
| Cash Flows From Investing Activities | ||
| PPE Investments | 38 | 38 |
| Other Investing Activity | -2,175 | -2,175 |
| Investing Cash Flow | $-2,136 | $-2,136 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 6,288 | 6,288 |
| Financing Cash Flow | $6,288 | $6,288 |
| Beginning Cash Position | 686 | 686 |
| End Cash Position | 2,568 | 2,568 |
| Net Cash Flow | $1,882 | $1,882 |
| Free Cash Flow | ||
| Operating Cash Flow | -2,269 | -2,269 |
| Free Cash Flow | -2,269 | -2,269 |